Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.4B
Avg Funding
$56.7M
Cities
21

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$100.0M
raised

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Jan 2022
Series B

Founder Contacts

41,000+ verified contacts

Newton, United States
$29.2M
raised

Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.

Jan 2022
Series B

Founder Contacts

41,000+ verified contacts

Burlington, United States
$115.0M
raised

SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.

Jan 2022
Series B

Founder Contacts

41,000+ verified contacts

Grand Cayman, Cayman Islands
$30.0M
raised

SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$8.0M
raised

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Pleasanton, United States
$60.0M
raised

Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$75.0M
raised

ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Grand Cayman, Cayman Islands
$41.0M
raised

EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Chicago, United States
$15.0M
raised

Surgical Innovation Associates is a developer of implantable polymeric surgical devices for plastic, reconstructive, and general surgery.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Waltham, United States
$103.0M
raised

Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
La Jolla, United States
$62.0M
raised

PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Phoenix, United States
$50.0M
raised

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$2.0M
raised

KitoTech Medical is a medical device company developing and commercializing products for wound closure and wound care.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

La Tronche, France
$13.3M
raised

PDC*line Pharma develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells.

Dec 2021
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$156.0M
raised

Quell Therapeutics is a cell therapy company

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Singapore, Singapore
$95.0M
raised

RWDC Industries develops sustainable biodegradable solutions, with a focus on biodegradable, water-based coatings for paper-based packaging.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

New York, United States
$91.0M
raised

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Gwynedd, United States
$35.0M
raised

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Kedalion Therapeutics is a biotechnology company that develops and commercializes transformative topical ophthalmic therapies.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$45.0M
raised

Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Paris, France
$17.4M
raised

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$20.0M
raised

Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Seattle, United States
$105.0M
raised

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Watertown, United States
$75.5M
raised

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Atlanta, United States
$75.0M
raised

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Nov 2021
Series B

Founder Contacts

41,000+ verified contacts

Showing 376 to 400 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

430 Biotechnology Series B Startups (November 2026) — Page 16 | VCBacked